Co-Authors
This is a "connection" page, showing publications co-authored by Antonio Abbate and Ross Arena.
Connection Strength
1.384
-
C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction. Front Cardiovasc Med. 2018; 5:178.
Score: 0.200
-
Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study. Clin Cardiol. 2018 Aug; 41(8):1004-1008.
Score: 0.195
-
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial). Circ Heart Fail. 2017 Nov; 10(11).
Score: 0.185
-
Dietary Fat, Sugar Consumption, and Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction. JACC Basic Transl Sci. 2017 Oct; 2(5):513-525.
Score: 0.185
-
Severely Impaired Cardiorespiratory Fitness in Patients With Recently Decompensated Systolic Heart Failure. Am J Cardiol. 2017 Nov 15; 120(10):1854-1857.
Score: 0.182
-
Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2). Clin Cardiol. 2017 Sep; 40(9):626-632.
Score: 0.179
-
Heart failure with preserved ejection fraction: refocusing on diastole. Int J Cardiol. 2015 Jan 20; 179:430-40.
Score: 0.151
-
Cardiopulmonary exercise testing during the COVID-19 pandemic. Prog Cardiovasc Dis. 2021 Jul-Aug; 67:35-39.
Score: 0.059
-
Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical Trials. J Cardiovasc Pharmacol. 2018 07; 72(1):68-70.
Score: 0.048